Type I interferon is induced shortly following viral infection and represents a first line of host defense against a majority of viral pathogens. Not surprisingly, both replication and latency of gammaherpesviruses, ubiquitous cancer-associated pathogens, are attenuated by type I interferon, although the mechanism of attenuation remains poorly characterized. Gammaherpesviruses also target histone deacetylases (HDACs), a family of pleiotropic enzymes that modify gene expression and several cell signaling pathways. Specifically, we have previously shown that a conserved gammaherpesvirus protein kinase interacts with HDAC1 and -2 to promote gammaherpesvirus replication in primary macrophages. In the current study, we have used genetic approaches to show that expression of HDAC1 and -2 is critical for induction of a type I interferon response following gammaherpesvirus infection of primary macrophages. Specifically, expression of HDAC1 and -2 was required for phosphorylation of interferon regulatory factor 3 (IRF3) and accumulation of IRF3 at the beta interferon promoter in gammaherpesvirus-infected primary macrophages. To our knowledge, this is the first demonstration of a specific role for HDAC1 and -2 in the induction of type I interferon responses in primary immune cells following virus infection. Furthermore, because HDAC1 and -2 are overexpressed in several types of cancer, our findings illuminate potential side effects of HDAC1-and -2-specific inhibitors that are currently under development as cancer therapy agents.
T
he ability of an infected cell to sense a viral pathogen and quell its replication is supported by the type I interferon (IFN) signaling pathway. Sensing of the incoming virion by the pattern recognition receptors initiates signaling events that culminate in the phosphorylation (1), dimerization (2) , and nuclear translocation of the interferon regulatory factor 3 (IRF3). Formation of a transcriptionally competent IRF3-containing protein complex at the beta interferon (IFN-␤) promoter subsequently mediates expression of type I IFN (2, 3) . Following transcription and secretion, type I IFN acts in an autocrine and paracrine manner to engage the type I IFN receptor. Downstream of the receptor, assembly of the Stat1/Stat2/IRF9 (ISGF3) complex leads to the expression of interferon-stimulated genes (ISGs) that foster an antipathogen cellular environment (4, 5) . Though significant strides have been made in understanding type I IFN induction and signaling, the molecular mechanisms of antiviral activity and the cross talk between type I IFN and other signaling pathways remain incompletely understood.
Histone deacetylase 1 (HDAC1) and HDAC2 are highly related proteins with overlapping functions that belong to a family of 11 pleiotropic enzymes that were canonically considered transcriptional repressors (6) . Importantly, this canonical role has been challenged by demonstrating enrichment of HDAC in transcriptionally active chromatin domains in Drosophila and human T cells (7, 8) . In addition to regulating gene expression, HDAC1 deacetylates important cellular regulators, such as p53 (9, 10) , and modifies several signaling pathways, including DNA damage response and autophagy (11, 12) .
Several groups have demonstrated that treatment of both transformed cell lines and primary immune cells with trichostatin A (TSA), a global HDAC inhibitor, prevents induction of type I IFN expression in response to Sendai virus, vesicular stomatitis virus, double-stranded RNA (dsRNA), CpG, and lipopolysaccharide (LPS) (13) (14) (15) (16) . Importantly, the contribution of individual HDACs to this phenomenon remained unclear until recently. In an elegant mechanism described by two independent publications, phosphorylation of HDAC6 by protein kinase C␣ (PKC␣) is required for deacetylation of ␤-catenin, which serves as a scaffold to bridge IRF3 and histone acetyltransferase CBP. Association of IRF3, CBP, and ␤-catenin is required to form a transcriptionally competent complex that enables IFN-␤ expression (13, 17) . In the absence of HDAC6, induction of IFN-␤ expression is arrested at the very late stage, as PKC␣ depletion had no effect on IRF3 phosphorylation and nuclear translocation but decreased enrichment of IRF3 at the IFN-␤ promoter (13, 17) . In contrast to the lack of IFN-␤ expression in TSA-treated primary cells, a small interfering RNA (siRNA)-mediated knockdown of HDAC1 in a sarcoma cell line increased type I IFN expression in response to doublestranded RNA (14) . Importantly, this phenotype may have been driven by a compensatory increase in the expression of HDAC2 that is known to occur under conditions when only HDAC1 is depleted (18, 19) and further modified by altered IFN signaling that is associated with cellular transformation (20, 21) .
The human gammaherpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) are ubiquitous pathogens that establish lifelong infection and are associated with several cancers (22) . Murine gammaherpesvirus 68 (MHV68) is genetically and biologically related to the human gammaherpesviruses and offers an experimental system that overcomes the challenges associated with the exquisite species specificity of EBV and KSHV (23, 24) . We have previously shown that orf36, a conserved gammaherpesvirus protein kinase encoded by MHV68, targets HDAC1 and -2 to facilitate viral DNA synthesis and replication in primary macrophages (25) . Because herpesvirus protein kinases encoded by EBV, MHV68, KSHV (26) , and herpes simplex virus 1 (HSV-1) (27) also attenuate antiviral effects of type I IFN, we used the phenotypes revealed by orf36 to probe the potential cross talk between HDAC1 and -2 and type I IFN responses. Using genetic approaches and physiologically relevant primary immune cells, we found that HDAC1 and -2 expression was required for induction of type I IFN transcription following MHV68 infection. The attenuated expression of type I IFN in HDAC1-and -2-depleted macrophages coincided with decreased enrichment of IRF3 at the IFN-␤ promoter and suboptimal IRF3 phosphorylation. Thus, we have capitalized on the known biological phenotypes of the herpesvirus protein kinase to uncover a previously unanticipated role of HDAC1 and -2 in antiviral responses during gammaherpesvirus infection.
MATERIALS AND METHODS
Animals, primary cell cultures, and OHT treatment of primary macrophages. All mice were housed and bred in a specific-pathogen-free barrier facility in accordance with federal and institutional guidelines. All experimental manipulations of mice were approved by the Institutional Animal Care and Use Committee of the Medical College of Wisconsin (AUA971). C57BL/6J (BL6) mice were obtained from Jackson Laboratories (Bar Harbor, ME). HDAC1/2 flox/flox (HDAC1/2 F/F) mice (28) were crossed to mice expressing modified estrogen receptor-Cre fusion protein under the control of the Rosa promoter (29) (obtained from Jackson Laboratories) to generate HDAC1/2 F/F ϫ ER-Cre mice as previously described (25) .
IRF3
Ϫ/Ϫ mice were generously provided by Michael Diamond (30) . Bone marrow was harvested from mice between 3 and 10 weeks of age. Primary bone marrow-derived macrophages were generated and treated with 4-hydroxytamoxifen (OHT) as previously described (25) . HDAC1/2 protein depletion was confirmed at 13 days posttreatment, before the initiation of the experiment. Throughout this study, macrophages of both Crepositive and -negative genotypes were identically treated with OHT; infections and experimental manipulations were initiated at 14 days of in vitro culture, in the absence of OHT.
Western blot analysis. Macrophages were collected into Laemmli buffer and analyzed as previously described (31) . Antibodies used were anti-HDAC1 (1:1,000; Millipore, Billerica, MA), anti-HDAC2 (1:10,000; Sigma-Aldrich, St. Louis, MO), antiviperin (1:1,000; Millipore), anti-orf6 (ssDBP, 1:1,000 [32] ), anti-ISG15 (1:3,000; provided by D. Lenschow, Washington University, St. Louis, MO), anti-␤-actin (1:20,000; Novus Biologicals, Littleton, CO), anti-Stat1 (1:3,000; Santa Cruz Biotechnology, Santa Cruz, CA), anti-phosphoserine 396-IRF3 (1:2,000; Cell Signaling, Danvers, MA), and anti-IRF3 (Active Motif, Carlsbad, CA) and a secondary goat anti-mouse or anti-rabbit horseradish peroxidase (HRP)-conjugated antibody (1:20,000; Jackson ImmunoResearch, Westgrove, PA).
qRT-PCR quantitation of viral and cellular mRNAs. Total RNA was harvested, DNase treated, reverse transcribed, and analyzed by quantitative reverse transcription-PCR (qRT-PCR) as described in reference 33. IRF3 expression was analyzed using the following primers: forward, 5=-ACT-GCG-TCT-AGG-CTG-GTG-GTT-ATT-3=, and reverse, 5=-TCT-GGA-CCT-GTC-TTG-TCC-TTG-CTT-3=.
Chromatin immunoprecipitation (ChIP). Primary macrophages were infected at a multiplicity of infection (MOI) of 10, and chromatin was collected at 4 h postinfection and subjected to immunoprecipitation as described previously (32, 34) . Chromatin was immunoprecipitated with anti-IRF3 (1 g; Active Motif, Carlsbad, CA), anti-histone H3 (1 g; Abcam, Cambridge, MA), anti-acetyl histone H4 (anti-AcH4, 1 g; Abcam), or rabbit IgG (Santa Cruz Biotechnology, Santa Cruz, CA). Coimmunoprecipitated DNA was purified and analyzed by RT-PCR using primers targeting the IFN-␤ promoter (forward, 5=-CCA-GGA-GCT-TGA-ATA-AAA-TGA-A-3=, and reverse, 5=-TGC-AGT-GAG-AAT-GAT-CTT-C-3=) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers described previously (32) .
IFN bioassay. Conditioned medium (CM) was collected from bone marrow-derived macrophages that were mock infected or infected with wild-type (wt) and N36S MHV68. CM was processed and analyzed as previously described (35) to measure antiviral activity. The concentration of IFN in CM was determined using the optical density at 450 nm (OD 450 ) as follows: log IU/ml ϭ log EC 50 ϩ log [(OD 450 Ϫ minimum)/(maximum Ϫ OD 450 )], where EC 50 is 50% effective concentration.
Interferon treatment. Macrophages were treated with recombinant mouse IFN-␤ (Biolegend, San Diego, CA) diluted in tissue culture medium. For infection experiments displayed in Fig. 6 , macrophages were treated immediately after virus adsorption with 5 U/ml, and infection was allowed to progress without further manipulation of medium.
EMCV infection and TLR ligand treatment. Macrophages were treated with 50 g/ml of poly(I)·poly(C) and 20 or 100 ng/ml of LPS (Sigma-Aldrich, St. Louis, MO) by direct addition to cellular medium. Encephalomyocarditis virus (EMCV) infection was done at a 50% tissue culture infective dose (TCID 50 ) of 10 at 37°C. After 8 h of treatment or infection, lysates were collected for Western analysis. Viperin mRNA levels were measured in EMCV-infected samples at 24 h postinfection (hpi) as previously described (35) . Phospho-IRF3 levels were measured by Western blotting using cell lysates collected at 4 h after treatment or infection.
Quantitation of viral DNA. Infected cells were washed with phosphate-buffered saline (PBS) and lysed in a buffer containing 10 mM TrisCl, 1 mM EDTA, 0.8% SDS, and 20 g/ml of proteinase K (Sigma-Aldrich, St. Louis, MO). Following overnight protein digestion at 56°C, DNA was extracted with phenol-chloroform and precipitated using standard sodium acetate-ethanol treatment. The DNA pellet was resuspended in TE (10 mM Tris-Cl [pH 8], 1 mM EDTA), and viral DNA was measured by real-time PCR using core gene 50 promoter primers (34) and normalized to corresponding GAPDH levels as previously described (34) .
Viral stock preparation and infections.
Wild-type MHV68 and N36S mutant virus stocks (26, 31) were prepared and titers were determined on NIH 3T12 cells as previously described (34) .
Statistical analysis. Student's t test (GraphPad Prism, La Jolla, CA) was used to measure statistical significance with an ␣ value of 0.05.
RESULTS

Expression of interferon-stimulated genes is attenuated in HDAC1 and -2-depleted primary macrophages in response to MHV68 infection.
We have previously shown that expression of orf36, a conserved gammaherpesvirus protein kinase, was required for efficient MHV68 replication in macrophages and the establishment of chronic infection in vivo (31, 32, 36) . In the absence of orf36, attenuated viral DNA synthesis and replication were rescued in HDAC1 and -2-depleted primary macrophages (25) . Thus, we hypothesized that a cellular pathway (or pathways) dependent on HDAC1 and -2 may restrict viral replication and that the antiviral impact of this pathway is neutralized by orf36. MHV68 orf36 attenuates the antiviral activity of type I IFN (26) ; thus, we entertained the possibility that HDAC1 and -2 may participate in type I IFN responses during gammaherpesvirus infection.
To determine the extent to which HDAC1 and -2 regulated the type I IFN response during MHV68 infection of primary macrophages, we utilized a mouse model of inducible HDAC1 and -2 depletion (25) . Primary bone marrow-derived macrophages generated from these mice were treated with 4-hydroxytamoxifen (OHT) during in vitro culture to induce depletion of HDAC1 and -2 ( Fig. 1A ; also previously described [25] ). OHT-treated Crepositive or -negative (control) macrophages were infected with MHV68, and expression of interferon-stimulated genes (ISGs) was measured at 24 h postinfection. As expected (35) , MHV68 infection resulted in increased protein levels of viperin, ISG15, and Stat1 in Cre-negative control macrophages (Fig. 1A) . In contrast, MHV68 infection failed to increase ISG expression in Cre-positive, HDAC1-and -2-depleted macrophages at 24 h postinfection (Fig.  1A ). The change (or lack thereof) in viperin protein expression was mirrored by the change in the levels of corresponding mRNA (Fig.  1B) . Furthermore, decreased viperin mRNA levels were observed in Cre-positive macrophages throughout the MHV68 replication cycle (8 and 48 h postinfection) (Fig. 1B) . Similarly, mRNA levels of Mx-1 and GBP-1, ISGs with known antiviral functions (37, 38) , were significantly reduced in MHV68-infected HDAC1 and -2-depleted macrophages compared to the Cre-negative controls ( Fig. 1C and D) . Exogenous IFN-␤ treatment induces expression of ISGs in HDAC1-and -2-depleted primary macrophages. Attenuated ISG expression in HDAC1-and -2-depleted macrophages could be attributed to decreased type I IFN induction or to attenuated signal transduction following IFN expression. To test the latter possibility, uninfected, HDAC1-and -2-depleted or control macrophages were treated with low levels of exogenous IFN-␤ (5 U/ml). Treatment with exogenous IFN-␤ resulted in a robust increase in viperin, Mx-1, and GBP-1 mRNA levels in Cre-negative primary macrophages (Fig. 2, black bars) . Cre-positive, HDAC1-and -2-depleted macrophages demonstrated a similar increase in mRNA levels of the examined ISGs following exogenous IFN-␤ treatment (Fig. 2, gray bars) . Thus, depletion of HDAC1 and -2 in primary macrophages did not compromise their ability to respond to exogenous type I IFN.
Expression of type I IFN is attenuated in HDAC1-and -2-depleted primary macrophages in response to MHV68 infection. Expression of ISGs was attenuated in MHV68-infected HDAC1-and -2-depleted macrophages (Fig. 1) . In contrast, HDAC1-and -2-depleted macrophages displayed robust ISG induction in response to exogenous type I IFN (Fig. 2) . Thus, we hypothesized that type I IFN expression is attenuated in HDAC1-and -2-depleted macrophages following MHV68 infection. Over a dozen type I IFN family members interact with type I IFN receptor to induce signaling (39) . Therefore, we employed an EMCV bioassay (35) to capture production of any type I IFN by MHV68-infected macrophages at 4 h postinfection. As expected, a significant increase in antiviral activity was observed in the tissue culture medium of infected Cre-negative macrophages, regardless of whether the cells were infected with the wild type or orf36 null virus mutant (N36S) (Fig. 3A, black bars) . In contrast, Cre-positive, HDAC1-and -2-depleted macrophages generated significantly lower levels of antiviral activity (Fig. 3A, gray bars) . Similar results were obtained at 8 hpi (data not shown). This was not simply a kinetic delay, as antiviral activity remained low in the conditioned medium of Cre-positive macrophages at 24 h postinfection (Fig. 3B) .
The lack of antiviral activity within the culture supernatant of Cre-positive cultures could be the result of an obstruction of type I IFN secretion or lack of type I IFN transcription. In agreement with the latter hypothesis, a minimal increase in IFN-␣ and IFN-␤ mRNA levels was observed in infected HDAC1-and -2-depleted macrophages at 4 h postinfection ( Fig. 3C and D) . Thus, primary macrophages relied on HDAC1 and -2 for optimal type I IFN expression in response to MHV68 infection.
Expression of interferon-stimulated genes is attenuated in HDAC1 and -2-depleted primary macrophages upon treatment with LPS or poly(I)·poly(C) and upon EMCV infection. To establish whether the role of HDAC1 and -2 in type I IFN induction was specific for MHV68 infection, HDAC1-and -2-depleted or control macrophages were infected with EMCV or treated with poly(I)·poly(C) or lipopolysaccharide (LPS), ligands of Toll-like receptor 3 (TLR3) or TLR4, respectively, that induce IRF3-mediated IFN-␤ transcription (40, 41) . As expected, all treatments induced ISG15 expression in control Cre-negative macrophages (Fig. 3E) . Interestingly, ISG15 expression (Fig. 3E ) and viperin mRNA levels (Fig. 3F to H) were decreased in Cre-positive, HDAC1-and -2-depleted cells, suggesting that the role of HDAC1 and -2 in type I IFN induction is not limited to MHV68 infection.
IRF3 phosphorylation and association with IFN-␤ promoter in response to MHV68 are dependent on HDAC1 and -2. We have previously shown that IRF3 is required for type I IFN expression by MHV68-infected macrophages, especially during the first 24 h of infection (35) . Because type I IFN expression relies on recruitment of IRF3 to the IFN-␤ promoter, we measured IRF3 accumulation at the IFN-␤ promoter in Cre-negative or -positive MHV68-infected macrophages. Enrichment of IRF3 at the IFN-␤ promoter was significantly increased at 4 h postinfection in Crenegative macrophages compared to uninfected cells of the same genotype (Fig. 4A) . In contrast, levels of IRF3 enrichment at the IFN-␤ promoter were similar in mock-and MHV68-infected Crepositive macrophages, and IRF3 enrichment was of the same magnitude as that measured in MHV68-infected IRF-3 Ϫ/Ϫ macrophages used as a specificity control (Fig. 4A) . Furthermore, the lack of IRF3 enrichment at the IFN-␤ promoter was not due to decreased IRF3 expression in Cre-positive macrophages ( Fig. 4B  and H) . Thus, HDAC1 and -2 were required for IRF3 recruitment to the IFN-␤ promoter in response to MHV68 infection.
In addition to IRF3 recruitment, we also analyzed the enrichment of histone H3 (Fig. 4C and E) and acetylated histone H4 (AcH4) (Fig. 4D and F) at the IFN-␤ promoter and GAPDH coding sequence (specificity control). Increased levels of AcH4 were associated with both the GAPDH coding sequence and IFN-␤ promoter in HDAC1-and -2-depleted Cre-positive macrophages independent of MHV68 infection, reflecting the role of HDAC1 and -2 in histone acetylation. Importantly, increased levels of AcH4 did not correlate with increased expression of either GAPDH or IFN-␤ (Fig. 3D and data not shown) .
IRF3 recruitment to the IFN-␤ promoter is the result of several upstream signaling events that induce phosphorylation (1) of IRF3. To investigate whether IRF3 was phosphorylated in Crepositive, HDAC1-and -2-depleted cells, levels of phosphoserine 396 of IRF3 were measured in MHV68-infected or LPS-treated macrophages. At 4 h after infection or treatment, IRF3 was phosphorylated in both MHV68-infected and LPS-treated Cre-negative control macrophages (Fig. 4G) . In contrast, levels of phospho-IRF3 were significantly reduced upon depletion of HDAC1 and -2, in spite of similar levels of total IRF3 (Fig. 4B, G, and H) . Therefore, HDAC1 and -2 were necessary for IRF3 phosphorylation and its subsequent enrichment at the IFN-␤ promoter.
Immediate-early and early viral gene expression is not altered in HDAC1-and -2-depleted primary macrophages.
We have previously shown that in the absence of a type I IFN response (i.e., in macrophages lacking type I IFN receptor), expression of immediate-early and early MHV68 genes is dramatically in- creased (35) . Having established that type I IFN expression is attenuated in HDAC1-and -2-depleted macrophages (Fig. 3) , we wanted to determine the extent to which this attenuation altered viral gene expression.
RTA is an immediate-early gammaherpesvirus transactivator that is essential for MHV68 and KSHV replication and reactivation from latency (42) (43) (44) (45) (46) . Surprisingly, in spite of highly attenuated type I IFN expression (Fig. 3) , RTA mRNA levels were similar in Cre-negative and Cre-positive macrophages ( Fig. 5A and B) . Furthermore, equal expression of orf57, an early gene directly regulated by RTA, was observed in infected macrophages of both genotypes (Fig. 5C) .
We have previously observed that decreased viral DNA synthesis in the absence of MHV68 kinase orf36 (N36S viral mutant) was rescued in HDAC1-and -2-depleted macrophages (Fig. 6) (25) . MHV68 encodes six proteins expressed with early kinetics (ssDBP and orf9, -40, -44, -56, and -59) that are required for viral DNA replication. Expression of all six genes was not altered by the macrophage genotype (Cre positive or negative), and the levels of expression were similar in wt MHV68-and N36S mutant-infected macrophages (Fig. 5D to I) , suggesting that the rescued DNA synthesis of the N36S mutant virus was not due to altered expression of viral DNA synthesis genes. Thus, in contrast to that observed in macrophages lacking type I IFN receptor (35) , infection of HDAC1-and -2-depleted macrophages did not result in increased viral immediate-early or early gene expression, in spite of substantial attenuation of type I IFN signaling. Attenuated IFN signaling is responsible for increased replication of orf36-null MHV68 mutant in HDAC1-and -2-depleted primary macrophages. We have previously shown that depletion of HDAC1 and -2 in primary macrophages rescues viral DNA synthesis and replication of the orf36-null N36S MHV68 mutant (25) . This rescue phenotype was concurrent with significant attenuation in type I IFN signaling observed in HDAC1-and -2-depleted macrophages in this study ( Fig. 1 and 3) . To determine if the attenuated type I IFN signaling was responsible for the rescue of the N36S MHV68 mutant, HDAC1-and -2-depleted primary macrophages or controls were infected with wt MHV68 or the N36S mutant. Immediately after adsorption, duplicate cultures were treated with 5 U/ml of exogenous IFN-␤ to mimic levels of antiviral activity typically produced by wt macrophages in response to MHV68 infection (Fig. 3A and B) (35) . As expected, attenuated viral DNA accumulation was observed in Cre-negative control macrophages infected with the N36S mutant, compared to wt MHV68 (Fig. 6, bars 1 and 2) . IFN-␤ treatment did not further attenuate viral DNA synthesis in either wt MHV68-or N36S-infected cells (Fig. 6 , compare bars 3 and 4 to 1 and 2, respectively), indicating that wt MHV68 can counteract the effect of low levels of exogenous IFN-␤. Upon depletion of HDAC1 and -2 (Cre-positive macrophages), accumulations of viral DNA were similar in wt MHV68 and N36S mutant infections (Fig. 6 , bars 5 and 6), as reported in the previous study (25) . Addition of exogenous IFN-␤ did not attenuate viral DNA synthesis in wt MHV68-infected HDAC1 and -2-depleted macrophages (Fig. 6, bars 5 and  7) . In contrast, addition of exogenous IFN-␤ attenuated accumulation of viral DNA in N36S-infected Cre-positive macrophages (Fig. 6, bars 6 and 8) , indicating that the attenuated type I IFN signaling is primarily responsible for the rescued N36S mutant replication in HDAC1 and -2-depleted macrophages.
DISCUSSION
In this study, we identified a novel and critical role for HDAC1 and -2 in the induction of the type I IFN response in primary mouse macrophages. Using genetic approaches, we demonstrated that HDAC1 and -2-depleted macrophages are unable to induce adequate expression of type I IFN in response to MHV68 infection. Specifically, HDAC1 and -2 facilitated IRF3 phosphorylation and subsequent recruitment of IRF3 to the IFN-␤ promoter and were also required to induce IFN signaling following stimulation of TLR3 or TLR4. Based on the current and published studies, we propose the following working model (Fig. 7) . Upon infection of primary macrophages with MHV68, HDAC1 and -2 are engaged downstream of pattern recognition receptors to facilitate phosphorylation of IRF3, IRF3 recruitment to the IFN-␤ promoter, and subsequent type I IFN expression and antiviral signaling. However, the current study also provides indirect evidence (discussed below) that HDAC1 and -2 may engage signaling pathways that positively affect steps of viral replication, including RTA expression. Thus, by targeting HDAC1 and -2, including via the orf36 protein kinase, the virus maintains a balance between the proviral and antiviral functions of HDAC1 and -2.
HDACs and type I IFN response. In this study, we show that primary macrophages rely on class I HDAC1 and -2 for optimal induction of the type I IFN response following MHV68 and EMCV infection as well as engagement of TLR4 or TLR3. Interestingly, two independent groups have recently reported that HDAC6, a class II HDAC, facilitates type I IFN expression by deacetylating ␤-catenin, thus enabling association of IRF3 with CBP/p300 (13, 17) . Significantly, this mechanism also operated in primary cells, including macrophages (13) . HDAC6 deficiency precluded IRF3 enrichment at the IFN-␤ promoter but did not affect IRF3 dimerization, phosphorylation, or nuclear translocation (13) . In contrast to that observed in HDAC6-depleted cells, HDAC1 and -2 depletion in the current study attenuated both IRF3 phosphorylation and IRF3 recruitment to the IFN-␤ promoter (Fig. 4) . This suggests that HDAC1 and -2 support events upstream of the assembly of a competent IRF3 transcriptional complex that is facilitated by HDAC6. Thus, class I and class II HDACs appear to have unique effects on type I IFN expression; dissecting the molecular mechanism of such effects and a possible cooperation between HDAC1, -2, and -6 is an important direction of the future studies.
In the current study, HDAC1 and -2 depletion had no effect on the IFN-␤-dependent expression of conventional ISGs, such as Mx-1 and GBP-1 (Fig. 2) , indicating that once type I IFN is expressed, these two HDACs are dispensable for the classical signaling pathway in macrophages. Interestingly, HDAC1 and -2 appear to differentially inhibit IFN-dependent STAT3 transcriptional activity (47) . Although this finding awaits verification in primary cells, it is tempting to speculate that HDAC1 and -2 may further regulate cross talk between the classical, ISGF3-dependent, and ISGF-3-independent type I IFN signaling.
Previous reports showed that treatment of cell lines and fibroblasts with high doses of TSA results in attenuation of IFN-driven ISG expression, including reduced recruitment of RNA polymerase II to several Stat1-dependent promoters (48) (49) (50) . These results are in conflict with our finding that HDAC1 and -2 depletion does not affect responsiveness of primary macrophages to exogenous IFN-␤ (Fig. 2) . The differences between the current and published studies are likely to be attributed to the global HDAC inhibition and/or nonspecific side effects of high doses of TSA (100 to 300 nM) used in the published studies (48) (49) (50) . In contrast, our discovery that HDAC1 and -2 facilitate IFN-␤ expression is in agreement with multiple published observations that low, nontoxic doses of TSA inhibit type I IFN expression in response to diverse ligands of pattern recognition receptors in both transformed cell lines and primary immune cells (13) (14) (15) (16) .
Role of HDAC1 and -2 in gammaherpesvirus infection. The involvement of HDAC1 and -2 in the induction of the type I IFN response illuminates a novel aspect of the interaction between herpesviruses and class I HDACs. Multiple reports identified viral proteins encoded by all three families of herpesviruses that target class I HDACs, including HDAC1 and -2, presumably to relieve HDAC-mediated repression of viral genes (51) (52) (53) (54) (55) (56) (57) (58) . Furthermore, global HDAC inhibition induces reactivation of EBV, KSHV, and MHV68 (59-61); however, it is not known whether HDACs directly affect viral gene expression during reactivation. Based on the results of the current study, it is now plausible that at least some of the herpesvirus-encoded HDAC regulators counteract the antiviral role of HDAC1 and -2 in type I IFN induction.
We have recently reported that orf36, a conserved gammaherpesvirus protein kinase encoded by MHV68, interacts with HDAC1 and -2 in infected primary macrophages (25) . However, targeting of HDAC1 and -2 by orf36 is not likely to affect type I IFN expression, as levels of secreted antiviral activity and transcription of IFN-␣ and IFN-␤ are similar in macrophages infected with wt MHV68 or the orf36-null N36S mutant (Fig. 3) . In spite of similar expression of type I IFN, the N36S mutant is more sensitive to antiviral effects of type I IFN (26, 35) (Fig. 6 ). This suggests that in primary macrophages, orf36 functions downstream of type I IFN receptor to selectively counteract antiviral effects of type I IFN. Whether HDAC1 and -2 are involved in such antiviral effects remains a subject for future investigation.
Intriguingly, HDAC1 and -2 may have both pro-and antiviral effects in the context of herpesvirus infection. In fact, HDAC1 facilitates transcription of late genes in herpes simplex virus 1 (HSV-1) infection (62) . We previously reported that primary macrophages that lack type I IFN receptor demonstrate a significant increase in transcription of both immediate-early and early MHV68 genes and allow a 50-fold increase in MHV68 replication (35) . Intriguingly, we have not observed increased viral gene expression or increased replication of wt MHV68 in HDAC1-and -2-depleted macrophages that display minimal induction of type I IFN signaling. It is possible that low levels of type I IFN signaling in Cre-positive macrophages were sufficient to suppress viral gene expression; however, this argument is counteracted by the rescue of N36S replication in HDAC1-and -2-depleted macrophages, a rescue that is reversed by exogenous treatment with IFN-␤ (Fig.  6) . Thus, it is tempting to speculate that, similar to the positive HDAC1 effects on HSV-1 late gene expression, HDAC1 and -2 may have proviral effects and facilitate viral gene expression in infected macrophages. Some of these proviral effects may be due to the involvement of HDAC1 and -2 in other signaling pathways. Interestingly, HDAC1 and -2 support peak activation of ataxia telangiectasia mutated (ATM) kinase in the context of a DNA damage response (63) . Because the DNA damage response and, specifically, ATM are required for optimal MHV68 replication in primary macrophages (31) , depletion of HDAC1 and -2 may negatively affect MHV68 replication via attenuation of the DNA damage response. Other HDAC1 and -2-regulated pathways, such as autophagy, may also contribute to the putative proviral effects of these HDACs on MHV68 replication.
HDAC1 and -2 inhibitors in cancer therapy. The results of the current study highlight the impact of HDAC1 and -2 on the innate immune response in macrophages, which is of particular interest given the increasing usage of HDAC inhibitors (HDACi) in cancer therapy. Two global HDACi, vorinostat (suberoylanilide hydroxamic acid [SAHA] ) and romidepsin, are FDA approved for the treatment of cutaneous T-cell lymphomas, with several more HDACi undergoing clinical trials (64) . Further, the testing of HDACi for additional diseases is being extensively explored (65) . Vorinostat has been shown to induce latent HIV-1 transcription and may facilitate viral reactivation (66) . Despite the expansion of HDACi usage, little is known about how these pharmaceuticals might affect gammaherpesviruses, which infect the majority of the adult population (22) . Several recent clinical reports highlight the development of EBV-associated lymphomas following HDACi treatment (67, 68) . Interestingly, Smeltzer et al. report that upon cessation of HDACi treatment, EBV-associated lymphoproliferative disease regressed, suggesting a link between HDACi and EBV reactivation (68) . HDAC1 and -2 are overexpressed in several types of cancer and are attractive targets for the next generation of cancer therapy, currently under development (6) . The results of our study provide important insight into potential biological effects of such inhibitors, effects that have to be considered in light of the high seroprevalence of EBV infection.
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